How neoliberal capitalism and biomedical reductionism are reshaping psychedelics into a $10B+ mental health industry—while ignoring cultural roots and systemic trauma
Original framing: “Why pharma firms are betting billions on psychedelic drugs despite setbacks” — Nature
The original framing erases the fact that psychedelics were first cultivated, ritualized, and understood as sacred by Indigenous peoples, who faced violent suppression (e.g., the U.S. peyote bans, Canadian prohibitions on sacred ceremonies). Companies like Compass Pathways and Field Trip Labs are now profiting from substances that were never 'discovered' but *stolen*—a pattern mirrored in the biopiracy of African medicinal plants or Māori *rātā* (cordyline) extracts. Indigenous-led initiatives, such as the *Church of the Sacred Mushroom* or the *Ayahuasca Healing Retreats* in Peru, operate on principles of reciprocity and communal care, directly contradicting the extractive model of pharma. The absence of Indigenous voices in these narratives reinforces the myth of Western 'innovation' while obscuring the original stewards of these substances.
The psychedelic industry’s rise is not just a scientific or economic story but a *cultural and colonial one*—where sacred substances are being repackaged as commodities within a mental health system that pathologizes distress while ignoring its root causes.
The original framing obscures how Indigenous stewardship, historical resistance, and cross-cultural wisdom have been systematically erased to justify corporate extraction, while the 'optimism' around psychedelics masks the risk of recreating the same exclusions as mainstream psychiatry. Solutions must center *Indigenous sovereignty*, *decentralized production*, and *collective healing*—challenging the trickster-like inversion of liberation into profit. The real revolution lies not in pharma’s labs, but in reclaiming these substances as tools for systemic change, where their cultural and ecological dimensions are restored to their rightful place at the center.